Referencies
1. De Oliveira Santos M. Estimativa/2020 – Incidência de Câncer no
Brasil. Rev Bras Cancerol . 2020;66(1).
doi:10.32635/2176-9745.RBC.2020v66n1.927
2. Santos M de O. Estimativa 2018: Incidência de Câncer no Brasil.Rev Bras Cancerol . 2018;64(1):119-120.
doi:10.32635/2176-9745.RBC.2018v64n1.115
3. Wiffen PJ, Derry S, Moore RA, et al. Oral paracetamol (acetaminophen)
for cancer pain. Cochrane Pain, Palliative and Supportive Care Group,
ed. Cochrane Database Syst Rev . Published online July 12, 2017.
doi:10.1002/14651858.CD012637.pub2
4. Portenoy RK, Lesage P. Management of cancer pain. The Lancet .
1999;353(9165):1695-1700. doi:10.1016/S0140-6736(99)01310-0
5. van den Beuken-van Everdingen MHJ, Hochstenbach LMJ, Joosten EAJ,
Tjan-Heijnen VCG, Janssen DJA. Update on Prevalence of Pain in Patients
With Cancer: Systematic Review and Meta-Analysis. J Pain Symptom
Manage . 2016;51(6):1070-1090.e9. doi:10.1016/j.jpainsymman.2015.12.340
6. Wiffen PJ, Wee B, Moore RA. Oral morphine for cancer pain. Cochrane
Pain, Palliative and Supportive Care Group, ed. Cochrane Database
Syst Rev . Published online April 22, 2016.
doi:10.1002/14651858.CD003868.pub4
7. Deng D, Fu L, Zhao YX, et al. The Relationship Between Cancer Pain
and Quality of Life in Patients Newly Admitted to Wuhan Hospice Center
of China. Am J Hosp Palliat Med . 2012;29(1):53-59.
doi:10.1177/1049909111418636
8. Dreidi MM, Hamdan-Mansour AM. Pain, Sleep Disturbance, and Quality of
Life Among Palestinian Patients Diagnosed with Cancer. J Cancer
Educ . 2016;31(4):796-803. doi:10.1007/s13187-015-0946-5
9. Mikan F, Wada M, Yamada M, et al. The Association Between Pain and
Quality of Life for Patients With Cancer in an Outpatient Clinic, an
Inpatient Oncology Ward, and Inpatient Palliative Care Units. Am J
Hosp Palliat Med . 2016;33(8):782-790. doi:10.1177/1049909116630266
10. Marec-Bérard P, Delafosse C, Foussat C. [Cancer-related bone pain
in children]. Arch Pediatr Organe Off Soc Francaise Pediatr .
2005;12(2):191-198. doi:10.1016/j.arcped.2004.11.026
11. Caraceni A, Portenoy RK. An international survey of cancer pain
characteristics and syndromes. IASP Task Force on Cancer Pain.
International Association for the Study of Pain. Pain .
1999;82(3):263-274.
12. Widhe B, Widhe T. Initial symptoms and clinical features in
osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am .
2000;82(5):667-674.
13. Ottaviani G, Jaffe N. The Epidemiology of Osteosarcoma. In: Jaffe N,
Bruland OS, Bielack S, eds. Pediatric and Adolescent
Osteosarcoma . Vol 152. Springer US; 2009:3-13.
doi:10.1007/978-1-4419-0284-9_1
14. Zernikow B, Szybalski K, Hübner-Möhler B, et al. Specialized
pediatric palliative care services for children dying from cancer: A
repeated cohort study on the developments of symptom management and
quality of care over a 10-year period. Palliat Med .
2019;33(3):381-391. doi:10.1177/0269216318818022
15. Madden K, Magno Charone M, Mills S, et al. Systematic Symptom
Reporting by Pediatric Palliative Care Patients with Cancer: A
Preliminary Report. J Palliat Med . Published online February 13,
2019. doi:10.1089/jpm.2018.0545
16. Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of
undertreatment in cancer pain. A review of published literature.Ann Oncol Off J Eur Soc Med Oncol . 2008;19(12):1985-1991.
doi:10.1093/annonc/mdn419
17. Cohen MZ, Easley MK, Ellis C, et al. Cancer Pain Management and the
JCAHO’s Pain Standards. J Pain Symptom Manage .
2003;25(6):519-527. doi:10.1016/S0885-3924(03)00068-X
18. WHO Guidelines for the Pharmacological and Radiotherapeutic
Management of Cancer Pain in Adults and Adolescents . World Health
Organization; 2018. Accessed March 19, 2019.
http://www.ncbi.nlm.nih.gov/books/NBK537492/
19. Maltoni M. Opioids, pain, and fear. Ann Oncol .
2008;19(1):5-7. doi:10.1093/annonc/mdm555
20. Jackson TM, Bittman M, Granowetter L. Pediatric Malignant Bone
Tumors: A Review and Update on Current Challenges, and Emerging Drug
Targets. Curr Probl Pediatr Adolesc Health Care .
2016;46(7):213-228. doi:10.1016/j.cppeds.2016.04.002
21. Senerchia AA, Macedo CR, Ferman S, et al. Results of a randomized,
prospective clinical trial evaluating metronomic chemotherapy in
nonmetastatic patients with high-grade, operable osteosarcomas of the
extremities: A report from the Latin American Group of Osteosarcoma
Treatment: Metronomic Therapy in Osteosarcoma Patients. Cancer .
2017;123(6):1003-1010. doi:10.1002/cncr.30411
22. On behalf of the Brazilian Collaborative Study Group of Ewing Family
of Tumors – EWING1 and the Brazilian Society of Pediatric Oncology –
SOBOPE, Becker RG, Gregianin LJ, et al. What is the impact of local
control in Ewing sarcoma: analysis of the first Brazilian collaborative
study group – EWING1. BMC Cancer . 2017;17(1).
doi:10.1186/s12885-017-3391-5
23. Eleutério SJP, Senerchia AA, Almeida MT, et al. Osteosarcoma in
patients younger than 12 years old without metastases have similar
prognosis as adolescent and young adults: Osteosarcoma in Children and
AYA. Pediatr Blood Cancer . 2015;62(7):1209-1213.
doi:10.1002/pbc.25459
24. Wong DL, Baker CM. Pain in children: comparison of assessment
scales. Pediatr Nurs . 1988;14(1):9-17.
25. Araujo LC de, Romero B. Pain: evaluation of the fifth vital sign. A
theoretical reflection. Rev Dor . 2015;16(4).
doi:10.5935/1806-0013.20150060
26. Bieri D, Reeve RA, Champion GD, Addicoat L, Ziegler JB. The Faces
Pain Scale for the self-assessment of the severity of pain experienced
by children: development, initial validation, and preliminary
investigation for ratio scale properties. Pain .
1990;41(2):139-150.
27. Snaman JM, Baker JN, Ehrentraut JH, Anghelescu DL. Pediatric
Oncology: Managing Pain at the End of Life. Pediatr Drugs .
2016;18(3):161-180. doi:10.1007/s40272-016-0168-2
28. Jacob J, Matharu JK, Palat G, et al. End-of-Life Treatments in
Pediatric Patients at a Government Tertiary Cancer Center in India.J Palliat Med . 2018;21(7):907-912. doi:10.1089/jpm.2017.0632
29. Chi N-C, Demiris G. Family Caregivers’ Pain Management in
End-of-Life Care: A Systematic Review. Am J Hosp Palliat Med .
2017;34(5):470-485. doi:10.1177/1049909116637359
30. Pakos EE, Nearchou AD, Grimer RJ, et al. Prognostic factors and
outcomes for osteosarcoma: an international collaboration. Eur J
Cancer Oxf Engl 1990 . 2009;45(13):2367-2375.
doi:10.1016/j.ejca.2009.03.005
31. Petrilli AS, Brunetto AL, Cypriano MDS, et al. Fifteen Years’
Experience of the Brazilian Osteosarcoma Treatment Group (BOTG): A
Contribution from an Emerging Country. J Adolesc Young Adult
Oncol . 2013;2(4):145-152. doi:10.1089/jayao.2013.0012
32. Brunetto AL, Castillo LA, Petrilli AS, et al. Carboplatin in the
treatment of Ewing sarcoma: Results of the first Brazilian Collaborative
Study Group for Ewing Sarcoma Family Tumors-EWING1: Carboplatin in the
Treatment of Ewing Sarcoma. Pediatr Blood Cancer .
2015;62(10):1747-1753. doi:10.1002/pbc.25562
33. Kreyer J, Ranft A, Timmermann B, et al. Impact of the
Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study
Group on local therapy and overall survival of Ewing sarcoma patients
after induction therapy. Pediatr Blood Cancer .
2018;65(12):e27384. doi:10.1002/pbc.27384
34. Spraker-Perlman HL, Barkauskas DA, Krailo MD, et al. Factors
influencing survival after recurrence in osteosarcoma: A report from the
Children’s Oncology Group. Pediatr Blood Cancer .
2019;66(1):e27444. doi:10.1002/pbc.27444
35. Fernández Urtubia B, Trevigno Bravo A, Rodríguez Zamora N, Palma
Torres C, Cid Barria L. Uso de opiáceos en niños con cáncer avanzado en
cuidados paliativos. Rev Chil Pediatría . 2016;87(2):96-101.
doi:10.1016/j.rchipe.2015.10.006
36. Weltgesundheitsorganisation, ed. WHO Guidelines on the
Pharmacological Treatment of Persisting Pain in Children with Medical
Illnesses . World Health Organization; 2012.
37. Friedrichsdorf S, Postier A. Management of breakthrough pain in
children with cancer. J Pain Res . Published online March
2014:117. doi:10.2147/JPR.S58862
38. Friedrichsdorf SJ. Pain Management in Children with Advanced Cancer
and During End-of-life Care. Pediatr Hematol Oncol .
2010;27(4):257-261. doi:10.3109/08880011003663416
39. Anghelescu DL, Tesney JM. Neuropathic Pain in Pediatric Oncology: A
Clinical Decision Algorithm. Pediatr Drugs . 2019;21(2):59-70.
doi:10.1007/s40272-018-00324-4
40. Petrilli AS, de Camargo B, Filho VO, et al. Results of the Brazilian
Osteosarcoma Treatment Group Studies III and IV: prognostic factors and
impact on survival. J Clin Oncol Off J Am Soc Clin Oncol .
2006;24(7):1161-1168. doi:10.1200/JCO.2005.03.5352
41. Heinemann M, Ranft A, Langer T, et al. Recurrence of Ewing sarcoma:
Is detection by imaging follow-up protocol associated with survival
advantage? Pediatr Blood Cancer . 2018;65(7):e27011.
doi:10.1002/pbc.27011
42. Reed DR, Hayashi M, Wagner L, et al. Treatment pathway of bone
sarcoma in children, adolescents, and young adults. Cancer .
2017;123(12):2206-2218. doi:10.1002/cncr.30589
43. Palermo TM, Chambers CT. Parent and family factors in pediatric
chronic pain and disability: An integrative approach: Pain .
2005;119(1-3):1-4. doi:10.1016/j.pain.2005.10.027